This was not simply due to diminished PD-1 receptor expression, because PD-1 amounts were even enhanced in Cblb-deficient CD4+ and CD8+ T cells in vitro (Figure 5A & 5B) or not significantly altered on Cblb-deficient tumor infiltrating T cells, respectively (Figure 5E). The gene discussed is CBLB; the disease is neoplasm.